# Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients

> **NCT07573059** · NA · RECRUITING · sponsor: **Immedica Pharma US Inc** · enrollment: 100 (estimated)

## Conditions studied

- ARG1 Deficiency

## Interventions

- **DEVICE:** Loargys Arginine Test System

## Key facts

- **NCT ID:** NCT07573059
- **Lead sponsor:** Immedica Pharma US Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-17
- **Primary completion:** 2027-07-15
- **Final completion:** 2027-07-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07573059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07573059, "Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT07573059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*